
Syngene International Ltd Downgraded to Strong Sell Amid Weak Financials and Valuation Concerns
2026-11-17 08:12:45Syngene International Ltd, a key player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMojo as of 16 Nov 2026. This revision reflects deteriorating financial performance, stretched valuation metrics, weakening technical indicators, and a declining quality score, signalling heightened risks for investors amid ongoing underperformance.
Read MoreSyngene International Gains 6.59%: Technical Shift Amid Persistent Financial Challenges
2026-11-15 14:00:05Key Events This Week 09 Nov: Rating upgraded to Sell on technical improvements 11 Nov: Technical momentum shifts amid mixed market signals 13 Nov: Week closes at Rs.444.70 (+6.59%) Week OpenRs.417.20 Week CloseRs.444.70+6.59% <div class="stat-l...
Read More
Syngene International Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials
2026-11-10 08:08:47Syngene International Ltd, a key player in the healthcare services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 9 November 2026. This change reflects a nuanced shift in the company’s technical outlook amid ongoing financial headwinds and valuation concerns. While the technical indicators have improved to a sideways trend, fundamental challenges persist, prompting a cautious stance from investors.
Read More
Syngene International Ltd is Rated Strong Sell
2026-11-09 10:10:56Syngene International Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 30 July 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 November 2026, providing investors with the latest perspective on the company’s position.
Read MoreSyngene International Ltd Gains 9.73%: 4 Key Factors Driving the Rally
2026-11-01 14:00:32Key Events This Week 26 Oct: Stock opens at Rs.359.75, declines 1.95% amid broad market gains 27 Oct: Modest recovery with 1.74% gain to Rs.366.00 28 Oct: Exceptional volume surge and intraday high of Rs.412.70, closing at Rs.411.70 (+12.49%) 29 Oct: Profit booking leads to 3.25% decline to Rs.398.30 30 Oct: Slight rebound of 1.08% to close the week at Rs.402.60 Week Open<div class...
Read More
Syngene International Ltd Surges on High-Value Trading Amid Institutional Interest
2026-10-28 15:00:10Syngene International Ltd, a prominent player in the healthcare services sector, witnessed a remarkable surge in trading value on 28 Oct 2026, driven by robust volume and significant price appreciation. Despite its strong intraday performance, the stock remains under scrutiny due to its recent downgrade to a Strong Sell by MarketsMOJO, reflecting a complex interplay of market enthusiasm and cautious institutional sentiment.
Read More
Syngene International Ltd Sees Exceptional Volume Surge Amid Strong Sell Rating
2026-10-28 15:00:08Syngene International Ltd, a prominent player in the healthcare services sector, witnessed an extraordinary surge in trading volume on 28 Oct 2026, accompanied by a robust price rally. The stock outperformed its sector and broader market indices, signalling renewed investor interest despite a recent downgrade in its mojo rating.
Read More
Syngene International Ltd Surges 7.54% to Day's High of Rs 395.95 — Outperforms Sector by 6.74 Percentage Points
2026-10-28 12:21:35The Sensex declined 0.69% on 28 Oct 2026, while Syngene International Ltd surged 7.54%, outperforming its Healthcare Services sector by 6.74 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read More
Syngene International Ltd Shows Mixed Technical Signals Amid Prolonged Downtrend
2026-10-28 08:01:00Syngene International Ltd, a small-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent 1.74% rise in its share price to ₹366.00, the stock remains under pressure with a strong sell rating and a significant year-to-date decline of 43.8%, underscoring the challenges facing investors amid mixed technical indicators.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16-Nov-2026 | Source : BSEIntimation of Schedule of Meetings with Analyst/Institutional Investor(s)
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12-Nov-2026 | Source : BSEIntimation of Schedule of Meeting with Analyst/Institutional Investor(s)
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
02-Nov-2026 | Source : BSEIntimation of Earnings Conference call transcript for Q2 FY2027
Corporate Actions
No Upcoming Board Meetings
Syngene International Ltd has declared 12% dividend, ex-date: 25 Jun 26
No Splits history available
Syngene International Ltd has announced 1:1 bonus issue, ex-date: 11 Jun 19
No Rights history available